Home / Resources / Nordic Life Science Days – Super Session on AI

Nordic Life Science Days – Super Session on AI

Video
Clinical
Event banner for the NLSDays 2024

While the timeline for bringing drugs to market has not shortened in the past 30 years, Citeline VP Claire Riches says AI has the potential to change that.

I still very much believe that the pharma industry, how we bring drugs to market, is a people business: patients, healthcare professionals, people supporting running the trials.
Claire Riches, Vice President, Clinical Solutions, Citeline
Related products
''
Citeline SmartSolutions
Optimize protocol design and study start up with Citeline SmartSolutions, powered by AI
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
Digital map showcasing the reach of Sitetrove, providing data from trial sites across the globe.
Sitetrove
The industry-leading suite of global clinical trial investigator and site intelligence

Related resources

AI assistant in biotechnology science experiment
JUL 15, 2024
Article
Clinical

The Promise and Peril of AI in Clinical Trials

Many smaller organizations have not yet implemented a specialized clinical trial disclosure system. Robust transparency, and perhaps even just compliance with multiple regulators, requires commitment from the C-suite for companies of all sizes.

AI
OCT 11, 2024
White paper
Clinical

AI in Pharma: Benefits, Risks, and the Road Ahead

AI is being used to streamline and accelerate each step of the drug development process from research through approval and marketing.

Synthetic Data Generation
SEP 05, 2024
Article
Clinical

The Real Value of Synthetic Data in Clinical Research: 3 Use Cases

Synthetic data, a form of generative AI, focuses on the creation of new content. See three use cases for using synthetic data in clinical research.

View all